(Q36318643)

English

Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades (English)

1 reference

Europe PubMed Central

13 August 2017

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

Jonathan I. Epstein

1

object named as

Jonathan I Epstein

1 reference

Europe PubMed Central

13 August 2017

author name string

Zhaoyong Feng

2

1 reference

Europe PubMed Central

13 August 2017

Bruce J Trock

3

1 reference

Europe PubMed Central

13 August 2017

Phillip M Pierorazio

4

1 reference

Europe PubMed Central

13 August 2017

language of work or name

0 references

publication date

8 February 2012

1 reference

Europe PubMed Central

13 August 2017

European Urology

1 reference

Europe PubMed Central

13 August 2017

61

1 reference

Europe PubMed Central

13 August 2017

5

1 reference

Europe PubMed Central

13 August 2017

1019-1024

1 reference

Europe PubMed Central

13 August 2017

Predictive factors of Gleason score upgrading in localized and locally advanced prostate cancer diagnosed by prostate biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

30 September 2017

Gleason score correlation between biopsy and prostatectomy specimens and prediction of high-grade Gleason patterns: significance of central pathologic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

30 September 2017

A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

30 September 2017

The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

30 September 2017

Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

30 September 2017

Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

30 September 2017

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

30 September 2017

Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

22 September 2018

Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

22 September 2018

Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

22 September 2018

Prostate specific antigen density to predict prostate cancer upgrading in a contemporary radical prostatectomy series: a single center experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

22 September 2018

External validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology among Japanese patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

22 September 2018

Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

22 September 2018

Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

22 September 2018

Prediction of Gleason score upgrading in low-risk prostate cancers diagnosed via multi (> or = 12)-core prostate biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

22 September 2018

Upgrading the Gleason score in extended prostate biopsy: implications for treatment choice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

22 September 2018

Prostate biopsy volume indices do not predict for significant Gleason upgrading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659370

22 September 2018

Upgrading of Gleason score 6 prostate cancers on biopsy after prostatectomy in the low and intermediate tPSA range

1 reference

https://pubmed.ncbi.nlm.nih.gov/22336380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of prostate-specific antigen and tumor volume in predicting needle biopsy grading error

1 reference

https://pubmed.ncbi.nlm.nih.gov/22336380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22336380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Errors in histological grading by prostatic needle biopsy specimens: frequency and predisposing factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22336380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of PSA velocity in predicting pathologic upgrade for Gleason 6 prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22336380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The proportion of free PSA and upgrading of biopsy Gleason score after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22336380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gleason score 7 prostate cancer on needle biopsy: relation of primary pattern 3 or 4 to pathological stage and progression after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22336380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score

1 reference

https://pubmed.ncbi.nlm.nih.gov/22336380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient risk stratification using Gleason score concordance and upgrading among men with prostate biopsy Gleason score 6 or 7

1 reference

https://pubmed.ncbi.nlm.nih.gov/22336380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22336380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting the risk of patients with biopsy Gleason score 6 to harbor a higher grade cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22336380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does prostate biopsy Gleason score accurately express the biologic features of prostate cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22336380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.EURURO.2012.01.050

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36318643&oldid=1907344545"